Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 29 , ISSUE 3 ( March, 2025 ) > List of Articles

Original Article

A Two-year Retrospective Observational Cohort Study of Benzodiazepine Overdose Cases in the Emergency Department

John Giftson, Darpanarayan Hazra, Gina M Chandy

Keywords : Benzodiazepine overdose, Deliberate self-harm, Drug overdose, Emergency Department, Intentional harm, Suicide

Citation Information : Giftson J, Hazra D, Chandy GM. A Two-year Retrospective Observational Cohort Study of Benzodiazepine Overdose Cases in the Emergency Department. Indian J Crit Care Med 2025; 29 (3):230-235.

DOI: 10.5005/jp-journals-10071-24925

License: CC BY-NC 4.0

Published Online: 28-02-2025

Copyright Statement:  Copyright © 2025; The Author(s).


Abstract

Background: Deliberate self-harm (DSH) is a significant health concern in developing countries, associated with high morbidity and mortality. Several factors influence patient outcomes. This study aimed to better understand the profile and outcomes of patients with benzodiazepine (BZD) overdose. Materials and methods: This two-year analysis conducted in the Emergency Department (ED) focused on patients with DSH and BZD toxicity. Key factors and outcomes were recorded and analyzed. Results: The study included 95 patients with BZD overdoses, some of whom had also taken other drugs. The mean age was 36.52 (SD: 14.2) years, with a female predominance (59.9%). The most common reasons for DSH were interpersonal issues, such as relationship failure (n = 48; 50.5%) and domestic fights or abuse (n = 37; 38.9%). Single-drug BZD overdose was more frequent among individuals aged 46–60 years. The predominant symptoms were drowsiness (n = 45; 47.4%) and nausea or vomiting (n = 32; 33.7%). Six patients (6.3%) required definitive airway stabilization in the ED, while two patients (2.1%) required inotropic support. Flumazenil was administered to 19 (20%) patients with no reported side effects. A majority (n = 49; 51.6%) of patients were admitted to the hospital, of whom 30 (61.2%) were discharged in stable condition, while 19 (38.8%) left against medical advice. No deaths were reported. Conclusion: Middle-aged females were most frequently involved in DSH cases. Single-drug BZD overdose was more common in this age-group. The predominant symptoms included drowsiness and gastrointestinal complaints. Most patients required hospital admission.


PDF Share
  1. Anthony L, Kulkarni C. Patterns of poisoning and drug overdosage and their outcome among in-patients admitted to the emergency medicine department of a tertiary care hospital. Indian J Crit Care Med 2012;16(3):130–135. DOI: 10.4103/0972-5229.102070.
  2. Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med 2015;49(4):493–501. DOI: 10.1016/j.amepre.2015.03.040.
  3. Krishnaram VD, Aravind VK, Vimala AR. Deliberate self-harm seen in a government licensed private psychiatric hospital and institute. Indian J Psychol Med 2016;38(2):137–141. DOI: 10.4103/0253-7176.
  4. López-Muñoz F, Álamo C, García-García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs. J Anxiety Disord 2011;25(4):554–562. DOI: 10.1016/j.janxdis.2011.01.002.
  5. Abhilash KPP, Murugan S, Rabbi NAS, Pradeeptha S, Kumar S, Selvaraj B, et al. Deliberate self-poisoning and harm: A meticulous quest of methods in vogue. J Fam Med Prim Care 2022;11(1):233–239. DOI: 10.4103/jfmpc.jfmpc_1184_21.
  6. Bhattacharya AK, Bhattacharjee S, Chattopadhyay S, Roy P, Kanji D, Singh OP. Deliberate self-harm: A search for distinct group of suicide. Indian J Psychol Med 2011;33(2):182–187. DOI: 10.4103/0253-7176.92057.
  7. Kang M, Galuska MA, Ghassemzadeh S. Benzodiazepine toxicity. StatPearls; 2023. Available from: https://www.statpearls.com.
  8. Bounds CG, Patel P. Benzodiazepines. StatPearls; 2024. Available from: https://www.statpearls.com.
  9. Benzodiazepines: Uses, types, side effects, and risks. Medical News Today. Available from: https://www.medicalnewstoday.com/articles/262809.
  10. Schmitz A. Benzodiazepine use, misuse, and abuse: A review. Ment Health Clin 2016;6(3):120–126. DOI: 10.9740/mhc.2016.05.120.
  11. Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists. Am J Emerg Med 2017;35(10):1414–1419. DOI: 10.1016/j.ajem.2017.04.023.
  12. Wang SH, Chen WS, Tang SE, Lin HC, Peng CK, Chu HT, et al. Benzodiazepines associated with acute respiratory failure in patients with obstructive sleep apnea. Front Pharmacol 2018;9:1513. DOI: 10.3389/fphar.2018.01513.
  13. Gameli PS, Huestis MA, Balloni A, Busardò FP, Carlier J. Metabolism and detection of designer benzodiazepines: A systematic review. Drug Metab Rev 2024;56(4):359–384. DOI: 10.1080/03602532.2024.2410747.
  14. Jones CM, Paulozzi LJ, Mack KA, Centers for Disease Control and Prevention (CDC). Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths-United States, 2010. MMWR Morb Mortal Wkly Rep 2014;63(40):881–885. PMID: 25299603.
  15. Benzodiazepines. Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 8 edition. Mc Graw Hill Medical. Available from: https://accessemergencymedicine.mhmedical.com.
  16. An H, Godwin J. Flumazenil in benzodiazepine overdose. CMAJ 2016;188(17–18):E537. DOI: 10.1503/cmaj.160357.
  17. Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication: A systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol 2016;118(1):37–44. DOI: 10.1111/bcpt.12434.
  18. Sivilotti ML. Flumazenil, naloxone and the ‘coma cocktail’. Br J Clin Pharmacol 2016;81(3):428–436. DOI: 10.1111/bcp.12731.
  19. Shoib S, Patel V, Khan S, Armiya'u AY, Saeed F, Swed S, et al. Over-the-counter drug use in suicidal/self-harm behavior: Scoping review. Health Sci Rep 2022;5(3):e662. DOI: 10.1002/hsr2.662.
  20. Mycyk MB. Poisoning and drug overdose. In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (Eds). Harrison's Principles of Internal Medicine, 20 edition. McGraw Hill Education; 2018. Available from: https://accessmedicine.mhmedical.com.
  21. Solhi H, Mostafazadeh B, Vishteh HRK, Ghezavati AR, Shooshtarizadeh A. Benefit effect of naloxone in benzodiazepines intoxication: Findings of a preliminary study. Hum Exp Toxicol 2011;30(7):535–540. DOI: 10.1177/0960327110374972.
  22. Schiller EY, Goyal A, Mechanic OJ. Opioid overdose. StatPearls; 2023. Available from: https://www.statpearls.com.
  23. Veiraiah A, Dyas J, Cooper G, Routledge PA, Thompson JP. Flumazenil use in benzodiazepine overdose in the UK: A retrospective survey of NPIS data. Emerg Med J 2012;29(7):565–569. DOI: 10.1136/emj.2010.095075.
  24. Zamani N, Hassanian-Moghaddam H, Zamani N. Strategies for the treatment of acute benzodiazepine toxicity in a clinical setting: The role of antidotes. Expert Opin Drug Metab Toxicol 2022;18(6):367–379. DOI: 10.1080/17425255.2022.2105692.
  25. Zellner T, Prasa D, Färber E, Hoffmann-Walbeck P, Genser D, Eyer F. The use of activated charcoal to treat intoxications. Dtsch Arztebl Int 2019;116(18):311–317. DOI: 10.3238/arztebl.2019.0311.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.